Navellier & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.48M Sell
9,474
-288
-3% -$75.9K 0.21% 118
2026
Q2
$2.16M Buy
9,762
+253
+3% +$70K 0.17% 123
2026
Q1
$2.81M Sell
9,509
-489
-5% -$145K 0.29% 83
2025
Q4
$2.73M Sell
9,998
-925
-8% -$251K 0.31% 79
2025
Q3
$2.95M Buy
10,923
+156
+1% +$42.4K 0.3% 87
2025
Q2
$2.97M Sell
10,767
-8
-0.1% -$2.18K 0.37% 78
2025
Q1
$3.04M Buy
+10,775
New +$2.66M 0.42% 64
2019
Q2
– Sell
-16,880
Closed -$2.78M – 278
2019
Q1
$2.78M Sell
16,880
-637
-4% -$113K 0.43% 64
2018
Q4
$3.3M Sell
17,517
-4,495
-20% -$830K 0.56% 35
2018
Q3
$3.75M Buy
22,012
+507
+2% +$85.4K 0.49% 60
2018
Q2
$3.52M Buy
+21,505
New +$3.51M 0.49% 51

Other funds holding CME

Navellier & Associates's CME Position: Q3 2026 in Review

Navellier & Associates reduced its CME Group (CME) stake by 3% in Q3 2026, selling an estimated $75.9K and leaving 9,474 shares worth $2.48M. The position accounts for 0.21% of the portfolio, ranked #118.

Navellier & Associates first reported a position in CME in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.75M in Q3 2018. 1,763 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Navellier & Associates held 9,474 shares of CME Group worth $2.48M as of Q3 2026.
  • Navellier & Associates sold 288 CME Group shares in Q3 2026, an estimated $75.9K.
  • CME Group made up 0.21% of Navellier & Associates's portfolio in Q3 2026, its #118 holding.
  • Navellier & Associates first reported a position in CME Group in Q2 2018 and has held it in 11 quarters since.
  • Navellier & Associates's CME Group position peaked at $3.75M in Q3 2018.
  • 1,763 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Navellier & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.